Patents by Inventor Hemant Malhari Mande

Hemant Malhari Mande has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polymorphic forms of VENCLEXTA
    Patent number: 10800777
    Abstract: The present disclosure relates to crystalline forms of venetoclax and process for their preparation. The present disclosure also relates to process for preparation of amorphous venetoclax.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: October 13, 2020
    Assignee: Mylan Laboratories Limited
    Inventors: Ramakoteswara Rao Jetti, Hemant Malhari Mande, Anjaneyaraju Indukuri, Narasimha Murthy Pilli, Rajesh Joshi, Anil Kumar Tripathi, Chandrakant Chaudhri, Kiran Pokharkar, Nagaraju Gottumukkala
  • Polymorphic forms of sofosbuvir
    Patent number: 10738071
    Abstract: The present disclosure provides novel crystalline sofosbuvir form-M3 and a process for the preparation of sofosbuvir form-M3. The crystalline sofosbuvir form-M3 disclosed herein may be useful in the formulation of pharmaceutical dosage forms.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: August 11, 2020
    Assignee: Mylan Laboratories Limited
    Inventors: Ramakoteswara Rao Jetti, Hemant Malhari Mande, Anjaneyaraju Indukuri, Narasimha Murty Pilli, Ravi Venkata Naga Vikas Chandra Dev, Vijaya Krishna Ravi
  • Forms of lumacaftor and processes for the preparation thereof
    Patent number: 10479782
    Abstract: The present disclosure provides amorphous lumacaftor, amorphous solid dispersions of lumacaftor, crystalline lumacaftor acetic acid solvate, crystalline lumacaftor ethyl acetate solvate, and processes for the preparation thereof. The lumacaftor forms disclosed herein may be useful for the preparation of oral dosage forms for treating cystic fibrosis transmembrane conductance regulator (CFTR) mediated diseases.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: November 19, 2019
    Assignee: Mylan Laboratories Limited
    Inventors: Ramakoteswara Rao Jetti, Hemant Malhari Mande, AnJaneyaraju Indukuri, Bommareddy Aggiramireddy, Neelima Bhagavatula, Amit Singh, Soumyajit Ghosh, Attanti Veera Venkata Srinivasarao, Umasankara Sastry Tummalapalli, Veera Venkata Satya Surya Appala Gosula
  • POLYMORPHIC FORMS OF VENETOCLAX
    Publication number: 20190233416
    Abstract: The present disclosure relates to crystalline forms of venetoclax and process for their preparation. The present disclosure also relates to process for preparation of amorphous venetoclax.
    Type: Application
    Filed: October 13, 2017
    Publication date: August 1, 2019
    Applicant: Mylan Laboratories Limited
    Inventors: Ramakoteswara Rao Jetti, Hemant Malhari Mande, Anjaneyaraju Indukuri, Narasimha Murthy Pilli, Rajesh Joshi, Anil Kumar Tripathi, Chandrakant Chaudhri, Kiran Pokharkar, Nagaraju Gottumukkala
  • POLYMORPHIC FORMS OF SOFOSBUVIR
    Publication number: 20190100550
    Abstract: The present disclosure provides novel crystalline sofosbuvir form-M3 and a process for the preparation of sofosbuvir form-M3. The crystalline sofosbuvir form-M3 disclosed herein may be useful in the formulation of pharmaceutical dosage forms.
    Type: Application
    Filed: March 17, 2017
    Publication date: April 4, 2019
    Applicant: Mylan Laboratories Limited
    Inventors: Ramakoteswara Rao Jetti, Hemant Malhari Mande, Anjaneyaraju Indukuri, Narasimha Murty Pilli, Ravi Venkata Haga Vikas Chandra Dev, Vijaya Krishna Ravi
  • NOVEL FORMS OF LUMACAFTOR AND PROCESSES FOR THE PREPARATION THEREOF
    Publication number: 20190055224
    Abstract: The present disclosure provides amorphous lumacaftor, amorphous solid dispersions of lumacaftor, crystalline lumacaftor acetic acid solvate, crystalline lumacaftor ethyl acetate solvate, and processes for the preparation thereof. The lumacaftor forms disclosed herein may be useful for the preparation of oral dosage forms for treating cystic fibrosis transmembrane conductance regulator (CFTR) mediated diseases.
    Type: Application
    Filed: September 28, 2016
    Publication date: February 21, 2019
    Applicant: Mylan Laboratories Limited
    Inventors: Ramakoteswara Rao Jetti, Hemant Malhari Mande, AnJaneyaraju Indukuri, Bommareddy Aggiramireddy, Neelima Bhagavatula, Amit Singh, Soumyajit Ghosh, Attanti Veera Venkata Srinivasarao, Umasankara Sastry Tummalapalli, Veera Venkata Satya Surya Appala Gosula